Navigation Links
VisiVite.com Files for Patent on Unique Macular Degeneration Supplement
Date:11/18/2008

Removal of Vitamin E from High Dose Eye Vitamins Provides Safety for Certain Patients.

Huntington, NY (PRWEB) November 18, 2008 -- VisiVite.com, an industry leader in eye health supplements, announced this week the filing for a United States patent application for an eye vitamin formulated to improve macular degeneration and provide safety for people on anticoagulation therapy.

The nutritional supplement, VisiVite i-Defense E-Free Formula, is based upon the groundbreaking 2001 Age-Related Eye Disease Study (AREDS) performed by the United States National Eye Institute. That research showed for the first time that high dose nutritional supplements could prevent the progression of macular degeneration. The AREDS formula included high doses of beta-carotene, Vitamins C and E, Zinc and Copper.

However, people who take Coumadin (warfarin) are frequently advised by physicians to avoid the high doses of Vitamin E used in AREDS because of the increased risk of bruising and hemorrhages.

The Grene Vision Group based in Southeastern Kansas and consisting of 42 optometrists and ophthalmologists in 20 offices, recommends VisiVite eye vitamin supplements for their patients. Spokesperson and partner, Dr. Steven Kuhl, explains, "We were impressed with the attention to quality and individualization of treatment that VisiVite supplements offer for our patients with macular degeneration. One example of this is VisiVite i-Defense E-Free Formula, which provides a customized level of nutritional therapy for our patients who cannot, for medical reasons, safely take high doses of Vitamin E."

The American Academy of Ophthalmology meeting, held earlier this month in Atlanta, Georgia, focused on the rapidly changing treatments and diagnostic tests for Age Related Macular Degeneration.

Since its introduction in early 2006, VisiVite i-Defense E-Free Formula has undergone annual sales growth of 260%, clearly fulfilling an unmet need.

VisiVite i-Defense E-Free Formula includes high dosages of Vitamin C and Zinc, the carotenoids Lutein and Zeaxanthin, Bilberry, Grapeseed Extract, and additional antioxidants.

About VisiVite.com:
Since 2001, VisiVite.com is dedicated to providing customers with state of the art eye vitamins to lessen the risk of age-related macular degeneration. Their products include Macular Degeneration Vitamins and Dry Eye Relief Vitamins. For more information and up-to-the minute AMD news, visit VisiVite.com .

###

Read the full story at http://www.prweb.com/releases/2008/11/prweb1617244.htm


'/>"/>
Source: PRWeb
Copyright©2008 Vocus, Inc.
All rights reserved

Related medicine news :

1. State Fund Files an 8.9 Percent Premium Increase for 2009
2. KV Pharmaceutical Company Files Form Reporting Delay in Filing Second Quarter Form 10-Q
3. Genesis Pharmaceuticals Files Counter Claims
4. Mary Hall, CEO of iHealthSpot, Inc., is Awarded Membership Into Fort Lauderdale City Limits "Profiles of Excellence"
5. Corporate Parent Hospital Partners of America Files Voluntary Chapter 11 Petition; Filings do not Include any Hospital Facilities
6. New York-Based Sanders Law Firm Files Claim for Good Samaritan Beaten by New York City Police Officers
7. Allscripts Files Definitive Proxy Statement and Announces Date for Annual Meeting of Stockholders
8. ULTCW Files Complaint Against UHW-W and Calls for Full Investigation by SEIU International
9. VirtualScopics Receives NASDAQ Delisting Notice; Company Files Appeal to Stay Delisting
10. Emageon Files Quarterly Report
11. New York-Based Sanders Law Firm Files Five Product Liability Lawsuits Against Pfizer on Behalf of Chantix™ Plaintiffs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2017)... ... 2017 , ... Thomas Jefferson University , in collaboration ... a $300,000 grant from The Pew Center for Arts & Heritage to build ... recognition of one’s own limits among health professions students. , The two-year ...
(Date:7/21/2017)... ... 21, 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, ... aggression to solve problems and pleads with world leaders to be more open about positive ... bring peace. He says there is a peaceful and positive way to solve all; yes, ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... Nature’s Tears® EyeMist®, the signature product of her research center at Bio-Logic Aqua ... world’s largest population and the greatest number of sufferers of blindness. “We think ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... why concussion rates are on the rise, say researchers presenting their work at ... Toronto, Ontario, Canada. , “The combination of evaluating the patterns of change in ...
(Date:7/20/2017)... ... July 20, 2017 , ... ... enterprise-grade IT operations analytics and application performance monitoring (APM) solutions, has expanded ... healthcare services providers. , According to Peter Ohrenberger, sales director at Nastel, ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)...  Bayer has awarded grants totaling more than $2 million ... prestigious Bayer Hemophilia Awards Program (BHAP). Four U.S. clinicians and ... and Uniformed Services University of the Health Sciences in ... recipients were announced last night during a reception at the ... Berlin, Germany . ...
(Date:7/11/2017)... Ill. , July 11, 2017  Sysmex ... and urinalysis diagnostic testing equipment as well as ... innovation: a way to make quality assurance easier ... processes. "Sysmex is well known for the innovation ... Quality Monitor elevates quality assurance processes to ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: